Clinical Trial Update: 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study [NA]

View source ↗

Summary

This is a pilot study evaluating Ga-68 labeled FAPI PET/CT for staging high-grade epithelial ovarian cancers, including high-grade serous ovarian cancer. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer

Drugs mentioned

• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: University Health Network, Toronto | Conditions: High Grade Serous Ovarian Cancer (HGSOC) | NA | Status: NOT_YET_RECRUITING